Inhibition of L-Type Ca2+ Channels by Carbon Monoxide

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 648)

Abstract

Inhibition of K+ channels in glomus cells underlies excitation of the carotid body by hypoxia. It has recently been proposed that hypoxic inhibition involves either activation of AMP activated protein kinase (AMPK) or inhibition of carbon monoxide (CO) production by heme oxygenase 2 (HO-2). In the vasculature, L-type Ca2+ channels are also O2 sensitive. Here, we have investigated the possible involvement of either AMPK or CO in the hypoxic inhibition of L-type Ca2+ channels. Using whole-cell patch clamp recordings from HEK293 cells stably expressing the human cardiac α1C2+channel subunit, we found that pre-treatment of cells with AICAR (to activate AMPK) was without effect on Ca2+ currents. CO, applied via the donor molecule CORM-2 caused reversible, voltage-independent Ca2+ channel inhibition of up to ca. 50%, whereas its inactive form (iCORM) was without significant effect. Effects of CO were prevented by the antioxidant MnTMPyP, but not by inhibition of NADPH oxidase (with either apocynin or diphenyleneiodonium), or xanthine oxidase (with allopurinol). Instead, inhibitors of complex III of the mitochondrial electron transport chain and a mitochondrial-targeted antioxidant (Mito Q), prevented the effects of CO. Our data suggest that hypoxic inhibition of L-type Ca2+ channels does not involve AMPK or CO. However, the known cardioprotective effects of HO-1 could arise from an inhibitory action of CO on L-type Ca2+ channels.

Keywords

Keywords Ca2+ channel L-type Carbon monoxide Reactive oxygen species Mitochondria Splice variant Patch clamp AMP kinase Electron transport chain 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Boczkowski, J., Poderoso, J. J.,&Motterlini, R. 2006, CO-metal interaction: Vital signaling from a lethal gas. Trends Biochem Sci 31: 614–621.PubMedCrossRefGoogle Scholar
  2. Chatterjee, P. K. 2007, Physiological activities of carbon monoxide-releasing molecules: Ca ira. Br J Pharmacol 150: 961–962.PubMedCrossRefGoogle Scholar
  3. Clark, J. E., Naughton, P., Shurey, S., Green, C. J., Johnson, T. R., Mann, B. E., Foresti, R.,&Motterlini, R. 2003, Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93: e2–e8.PubMedCrossRefGoogle Scholar
  4. D’Amico, G., Lam, F., Hagen, T.,&Moncada, S. 2006, Inhibition of cellular respiration by endogenously produced carbon monoxide. J Cell Sci 119: 2291–2298.PubMedCrossRefGoogle Scholar
  5. Evans, A. M., Mustard, K. J., Wyatt, C. N., Peers, C., Dipp, M., Kumar, P., Kinnear, N. P.,&Hardie, D. G. 2005, Does AMP-activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to calcium signaling in O2-sensing cells? J Biol Chem 280: 41504–41511.PubMedCrossRefGoogle Scholar
  6. Ewing, J. F., Raju, V. S.,&Maines, M. D. 1994, Induction of heart heme oxygenase-1 (HSP32) by hyperthermia: possible role in stress-mediated elevation of cyclic 3’:5’-guanosine monophosphate. J Pharmacol Exp Ther 271: 408–414.PubMedGoogle Scholar
  7. Fearon, I. M., Palmer, A. C. V., Balmforth, A. J., Ball, S. G., Mikala, G., Schwartz, A.,&Peers, C. 1997, Hypoxia inhibits the recombinant α1C subunit of the human cardiac L-type Ca2+ channel. J Physiol 500: 551–556.PubMedGoogle Scholar
  8. Fearon, I. M., Varadi, G., Koch, S., Isaacsohn, I., Ball, S. G.,&Peers, C. 2000, Splice variants reveal the region involved in oxygen sensing by recombinant human L-type Ca2+ channels. Circ Res 87: 537–539.PubMedGoogle Scholar
  9. Franco-Obregon, A., Urena, J.,&Lopez-Barneo, J. 1995, Oxygen-sensitive calcium channels in vascular smooth muscle and their possible role in hypoxic arterial relaxation. Proc Natl Acad Sci USA 92: 4715–4719.PubMedCrossRefGoogle Scholar
  10. Grilli, A., De Lutiis, M. A., Patruno, A., Speranza, L., Gizzi, F., Taccardi, A. A., Di, N. P., De, C. R., Conti, P.,&Felaco, M. 2003, Inducible nitric oxide synthase and heme oxygenase-1 in rat heart: direct effect of chronic exposure to hypoxia. Ann Clin Lab Sci 33: 208–215.PubMedGoogle Scholar
  11. Hardie, D. G., Hawley, S. A.,&Scott, J. W. 2006, AMP-activated protein kinase–development of the energy sensor concept. J Physiol 574: 7–15.PubMedCrossRefGoogle Scholar
  12. Kim, H. P., Ryter, S. W.,&Choi, A. M. 2006, CO as a cellular signaling molecule. Annu Rev Pharmacol Toxicol 46: 411–449.PubMedCrossRefGoogle Scholar
  13. Kumar, P. 2007, Sensing hypoxia in the carotid body: from stimulus to response. Essays Biochem 43: 43–60.PubMedCrossRefGoogle Scholar
  14. Lakkisto, P., Palojoki, E., Backlund, T., Saraste, A., Tikkanen, I., Voipio-Pulkki, L. M.,&Pulkki, K. 2002, Expression of heme oxygenase-1 in response to myocardial infarction in rats. J Mol Cell Cardiol 34: 1357–1365.PubMedCrossRefGoogle Scholar
  15. McGrath, J. J. 1984, The effects of carbon monoxide on the heart: an in vitro study. Pharmacol Biochem Behav 21 Suppl 1: 99–102.PubMedCrossRefGoogle Scholar
  16. Ortega-Saenz, P., Pascual, A., Gomez-Diaz, R.,&Lopez-Barneo, J. 2006, Acute Oxygen Sensing in Heme Oxygenase-2 Null Mice. J General Physiol 128: 405–411.CrossRefGoogle Scholar
  17. Taille, C., El-Benna, J., Lanone, S., Boczkowski, J.,&Motterlini, R. 2005, Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem 280: 25350–25360.PubMedCrossRefGoogle Scholar
  18. Williams, S. E., Wootton, P., Mason, H. S., Bould, J., Iles, D. E., Riccardi, D., Peers, C.,&Kemp, P. J. 2004, Hemoxygenase-2 is an Oxygen Sensor for a Calcium-Sensitive Potassium Channel. Science 306: 2093–2097.PubMedCrossRefGoogle Scholar
  19. Wu, L.&Wang, R. 2005, Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57: 585–630.PubMedCrossRefGoogle Scholar
  20. Wyatt, C. N., Mustard, K. J., Pearson, S. A., Dallas, M. L., Atkinson, L., Kumar, P., Peers, C., Hardie, D. G.,&Evans, A. M. 2007, AMP-activated protein kinase mediates carotid body excitation by hypoxia. J Biol Chem 282: 8092–8098.PubMedCrossRefGoogle Scholar
  21. Yet, S. F., Perrella, M. A., Layne, M. D., Hsieh, C. M., Maemura, K., Kobzik, L., Wiesel, P., Christou, H., Kourembanas, S.,&Lee, M. E. 1999, Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 103: R23–R29.PubMedCrossRefGoogle Scholar
  22. Yet, S. F., Tian, R., Layne, M. D., Wang, Z. Y., Maemura, K., Solovyeva, M., Ith, B., Melo, L. G., Zhang, L., Ingwall, J. S., Dzau, V. J., Lee, M. E.,&Perrella, M. A. 2001, Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89: 168–173.PubMedCrossRefGoogle Scholar
  23. Zuckerbraun, B. S., Chin, B. Y., Bilban, M., de Costa, d. J., Rao, J., Billiar, T. R.,&Otterbein, L. E. 2007, Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J 21: 1099–1106.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  1. 1.Division of Cardiovascular and Neuronal Remodelling, Leeds Institute of GeneticsHealth & Therapeutics University of LeedsLeeds LS2 9JTUK

Personalised recommendations